Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_assertion description "[In a nested case-control study, four polymorphisms in the Cox-2 gene (two in the promoter, -663 insertion/deletion, GT/(GT) and -798 A/G; one in intron 5-5229, T/G; one in 3'untranslated region (UTR)-8494, T/C) were genotyped in 726 cases of colorectal adenomas and 729 age- and gender-matched controls in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_assertion evidence source_evidence_literature NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_assertion SIO_000772 16205694 NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_assertion wasDerivedFrom befree-20140225 NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_assertion wasGeneratedBy ECO_0000203 NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP282201.RAkDwIzRnyBXXAO6jOLPR7PZbnpYhoPVlRaRUHc9bINtA130_provenance.